Table 4.
Risk factors for Phlebovirus seropositivity during a mission
| Risk factors | OR | 95% CI | P-value |
|---|---|---|---|
| Missions | |||
| Prior mission | 0.80 | 0.5–1.4 | 0.50 |
| Kosovo | 0.70 | 0.3–1.3 | 0.29 |
| Syria | 1.22 | 0.6–2.7 | 0.60 |
| Bosnia | 1.33 | 0.5–2.9 | 0.53 |
| Symptoms | |||
| Symptoms | 1.90 | 1.1–3.4 | 0.03* |
| Fever | 2.30 | 1.03–4.6 | 0.03* |
| Limb pain | 1.03 | 0.3–3.1 | 1 |
| Vacation | 1.88 | 0.9–4.1 | 0.12 |
| Outdoor activities | |||
| Sports | 1.40 | 0.5–4.6 | 0.70 |
| Running | 1.90 | 0.9–4.4 | 0.08a |
| Mountaineering | 1.17 | 0.6–2.1 | 0.60 |
| Cycling | 0.97 | 0.5–2.0 | 1.0 |
| Football | 1.00 | 0.1–4.5 | 1.0 |
| Animal contact | |||
| Dog | 1.10 | 0.6–2.0 | 0.80 |
| Cat | 1.40 | 0.7–2.6 | 0.27 |
| Rodent | 1.40 | 0.03–12.8 | 0.50 |
| Pets | 1.12 | 0.7–2.2 | 0.50 |
| Leishmania spp. ELISA | |||
| Leishmania antibodies | 1.50 | 0.7–3.0 | 0.20 |
| Leishmania positive | 2.70 | 1.2–5.8 | 0.009* |
| Leishmania borderline | 0.60 | 0.1–2.0 | 0.60 |
* Significant result (P < 0.05)
aStrong trend